What is Simulands?
Simulands is a Switzerland-headquartered entity specializing in the development and provision of advanced medical training simulation equipment. The company aims to enhance the efficacy and safety of medical education through realistic, high-fidelity simulation technology, positioning itself as a key player in the burgeoning health-tech and medical simulation market.
How much funding has Simulands raised?
Simulands has raised a total of $10.5M across 1 funding round:
Other Financing Round
$10.5M
Other Financing Round (2023): $10.5M with participation from SHS Group
Key Investors in Simulands
SHS Group
SHS Group, a UK-based entity with a history dating back to 1975, typically focuses on food products. Their participation in this funding round suggests a potential diversification strategy or a strategic interest in the health-tech sector.
What's next for Simulands?
The recent major strategic investment into Simulands signals a pivotal growth phase, likely enabling the company to scale its operations, expand its product portfolio, and deepen its market penetration. This influx of capital is expected to fuel further innovation in medical simulation technology, potentially leading to broader adoption across global healthcare institutions and educational facilities. The company's trajectory suggests a focus on solidifying its position as a leader in medical training solutions.
See full Simulands company page
